Foresee Pharmaceuticals Co (ROCO:6576) Other Operating Expense : NT$0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Foresee Pharmaceuticals Co Other Operating Expense?

Foresee Pharmaceuticals Co's Other Operating Expense for the three months ended in Mar. 2025 was NT$-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.0 Mil.

Foresee Pharmaceuticals Co's quarterly Other Operating Expense increased from Sep. 2024 (NT$0.0 Mil) to Dec. 2024 (NT$0.0 Mil) but then declined from Dec. 2024 (NT$0.0 Mil) to Mar. 2025 (NT$-0.0 Mil).

Foresee Pharmaceuticals Co's annual Other Operating Expense increased from Dec. 2022 (NT$-0.0 Mil) to Dec. 2023 (NT$-0.0 Mil) but then stayed the same from Dec. 2023 (NT$-0.0 Mil) to Dec. 2024 (NT$-0.0 Mil).

Foresee Pharmaceuticals Co Other Operating Expense Historical Data

The historical data trend for Foresee Pharmaceuticals Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Foresee Pharmaceuticals Co Other Operating Expense Chart

Foresee Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

Foresee Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Foresee Pharmaceuticals Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Foresee Pharmaceuticals Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Foresee Pharmaceuticals Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Foresee Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Foresee Pharmaceuticals Co Ltd (ROCO:6576) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115

Website

https://www.foreseepharma.com

Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilized injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.

Foresee Pharmaceuticals Co Headlines

No Headlines